Testing effectiveness (Phase 2)Study completedNCT03500679
What this trial is testing
Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and Older
Who this might be right for
Healthy
Janssen Research & Development, LLC 100